drugset / Trial / NCT00171028

A Study Of Valsartan Used To Treat Hypertension For Up To 56 Weeks In Children Ages 1 - 5 Years Who Have Hypertension

NCT00171028 ↗

Phase 3 Completed 90 enrolled Novartis
RandomizedParallel-groupDouble-blindTreatment

Summary

Drugs used to treat hypertension in adults should also be effective in treating high blood pressure in infants and children. This study will test the safety and efficacy of valsartan in lowering blood pressure in children 1 - 5 years old whose parents grant permission to participate.

Timeline

Start
2003-12
Primary completion
2006-11
Completion
2006-11

Outcome

Met primary endpoint

paper SBP and diastolic blood pressure were also significantly lower during phase 2 in valsartan recipients compared with placebo recipients. PMID 18591457 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Valsartan Unknown — —

Indications